You may pay as little as $10 for each of your next 6 COMBIVENT RESPIMAT prescriptions

You may be able to save on your prescription by enrolling in the COMBIVENT RESPIMAT Savings Card Program.*

To be eligible, you must meet the following criteria:

  • You are currently a resident of the United States, including the District of Columbia, or Puerto Rico
  • You must be at least 18 years of age
  • Your prescriptions are not paid in part or full by any state or federally funded program, including but not limited to Medicare or Medicaid, Medigap, VA, DOD, or TriCare

A helping hand along the way

Enroll in the COMBIVENT RESPIMAT Savings Card program and you won’t just be saving money on prescriptions. You’ll also receive support and useful information about COPD along the way.

A chronic condition like COPD can be more manageable when you have help. So, when you’re just learning to use your inhaler, you’ll get the guidance you need. And when questions may come up, we’ll provide answers—either by mail, e-mail or phone.

All you need to do is register for your Savings Card today— then you’ll know that support is heading your way.

Have questions?

Get answers from trained COMBIVENT RESPIMAT specialists.

1-800-867-1052

Mon-Fri, 8 AM to 8 PM ET

*Restrictions apply. See offer terms and conditions below.

With a COMBIVENT RESPIMAT Savings Card, eligible patients 18 years or older may pay as little as $10/month with a maximum savings up to $50/monthly prescription, for up to 6 prescriptions of COMBIVENT RESPIMAT. Eligible patients must pay for any costs beyond the $50 maximum savings for each monthly prescription. Eligible patients may re-enroll for additional 12-consecutive-month periods by reactivating expired card, on or before 12/31/2018.. If you live in Massachusetts or California, card expires on the earlier date of 12/31/2018, or date AB-rated generic equivalent is available. One card per patient, not transferrable, and cannot be combined with any other offer. Program not health insurance. Only valid for commercially insured patients in the 50 United States, territories, DC, and Puerto Rico. Not eligible if prescriptions are paid for in part/full by state or federally funded program(s), like Medicare Part D, Medicaid, Vet. Aff., Dept. of Def., or TriCare and where prohibited by law. Offer may change at any time, without notice.

SEE MORE

Indication for Use and Important Safety Information

COMBIVENT RESPIMAT (ipratropium bromide and albuterol) is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator (inhaler) who continue to have evidence of bronchospasm (airway narrowing) and who require a second bronchodilator.

Important Safety Information

Do not use COMBIVENT RESPIMAT if you are allergic to any of the ingredients in COMBIVENT RESPIMAT or to atropine or other similar drugs.

COMBIVENT RESPIMAT can cause the narrowing of the airways to get worse (paradoxical bronchospasm) which may be life threatening. If this happens, stop taking COMBIVENT RESPIMAT at once and call your doctor or get emergency help.

COMBIVENT RESPIMAT can cause serious heart-related side effects, such as palpitations, chest pain, rapid heart rate, high blood pressure, tremor, or nervousness. Call your doctor if you experience any of these symptoms.

COMBIVENT RESPIMAT may increase eye pressure which may cause or worsen some types of glaucoma.

Do not get the spray into your eyes.

COMBIVENT RESPIMAT may cause difficulty with urination.

If you have vision changes or eye pain or if you have difficulty with urination, stop taking COMBIVENT RESPIMAT and call your doctor right away.

Dizziness and blurred vision may occur with COMBIVENT RESPIMAT. Should you experience these symptoms, use caution when engaging in activities such as driving a car or operating appliances or other machines.

Do not use COMBIVENT RESPIMAT more often than your doctor has directed. Deaths have been reported with similar inhaled medicines in asthma patients who use the medicine too much. Seek immediate medical attention if your treatment with COMBIVENT RESPIMAT becomes less effective for symptomatic relief, your symptoms become worse, and/or you need to use the product more frequently than usual.

Allergic reactions may occur, including itching, swelling of the face, lips, tongue, or throat (involving difficulty in breathing or swallowing), rash, hives, bronchospasm (airway narrowing), or anaphylaxis. Some of these may be serious. If you experience any of these symptoms, stop taking COMBIVENT RESPIMAT at once and call your doctor or get emergency help.

Tell your doctor about all your medical conditions, especially if you have narrow-angle glaucoma, prostate or urinary problems, a history of heart conditions (such as irregular heartbeat, high blood pressure), seizures, thyroid disorder, diabetes, low potassium levels, or kidney or liver disease. Also tell your doctor if you are pregnant or nursing.

Tell your doctor about all medicines you are taking, especially heart medications or drugs to treat depression.

The most common side effects reported with use of COMBIVENT RESPIMAT include infection of the ears, nose, and throat, runny nose, cough, bronchitis, headache, and shortness of breath.

Click here for full Prescribing Information and Patient Instructions for Use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

SEE MORE

Indication for Use and Important Safety Information

COMBIVENT RESPIMAT (ipratropium bromide and albuterol) is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator (inhaler) who continue to have evidence of bronchospasm (airway narrowing) and who require a second bronchodilator.

Important Safety Information

Do not use COMBIVENT RESPIMAT if you are allergic to any of the ingredients in COMBIVENT RESPIMAT or to atropine or other similar drugs.

COMBIVENT RESPIMAT can cause the narrowing of the airways to get worse (paradoxical bronchospasm) which may be life threatening. If this happens, stop taking COMBIVENT RESPIMAT at once and call your doctor or get emergency help.

COMBIVENT RESPIMAT can cause serious heart-related side effects, such as palpitations, chest pain, rapid heart rate, high blood pressure, tremor, or nervousness. Call your doctor if you experience any of these symptoms.

COMBIVENT RESPIMAT may increase eye pressure which may cause or worsen some types of glaucoma.

Do not get the spray into your eyes.

COMBIVENT RESPIMAT may cause difficulty with urination.

If you have vision changes or eye pain or if you have difficulty with urination, stop taking COMBIVENT RESPIMAT and call your doctor right away.

Dizziness and blurred vision may occur with COMBIVENT RESPIMAT. Should you experience these symptoms, use caution when engaging in activities such as driving a car or operating appliances or other machines.

Do not use COMBIVENT RESPIMAT more often than your doctor has directed. Deaths have been reported with similar inhaled medicines in asthma patients who use the medicine too much. Seek immediate medical attention if your treatment with COMBIVENT RESPIMAT becomes less effective for symptomatic relief, your symptoms become worse, and/or you need to use the product more frequently than usual.

Allergic reactions may occur, including itching, swelling of the face, lips, tongue, or throat (involving difficulty in breathing or swallowing), rash, hives, bronchospasm (airway narrowing), or anaphylaxis. Some of these may be serious. If you experience any of these symptoms, stop taking COMBIVENT RESPIMAT at once and call your doctor or get emergency help.

Tell your doctor about all your medical conditions, especially if you have narrow-angle glaucoma, prostate or urinary problems, a history of heart conditions (such as irregular heartbeat, high blood pressure), seizures, thyroid disorder, diabetes, low potassium levels, or kidney or liver disease. Also tell your doctor if you are pregnant or nursing.

Tell your doctor about all medicines you are taking, especially heart medications or drugs to treat depression.

The most common side effects reported with use of COMBIVENT RESPIMAT include infection of the ears, nose, and throat, runny nose, cough, bronchitis, headache, and shortness of breath.

Click here for full Prescribing Information and Patient Instructions for Use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

You’re leaving this website

You are now leaving a Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) site. BIPI is not responsible for the way information is processed by sites linked to this one. Please review those sites' privacy policies and terms of use to understand how your information will be processed. Linking to any other site is at your own risk.

Continue